Home
Log In
Shipping
Information
Contact Us
Advanced Search
DISEASES & HEALTH CONDITIONS->
GENERAL HEALTH->
MEDICAL & SURGICAL
->
MEDICAL SPECIALTIES->
MENTAL HEALTH->
NURSING->
NURSING EQUIPMENT
PHARMACEUTICAL->
Stemcells
VETERINARY->
CHARTS & MODELS
VOUCHERS
CLEARANCE TITLES
FEATURED PRODUCTS ...
Home
/
MEDICAL & SURGICAL
/
E - G
/
General Medicine
/
Targeted Therapy in Non-small Cell Lung Cancer
General Medicine
Product 3857/4779
Previous
Return to the Product List
Next
Targeted Therapy in Non-small Cell Lung Cancer
larger image
ISBN 9780199743087
Author: GERBER
Publ Date: 2011-10-06
Edition:
Binding: Paperback / softback
$34.78
Sale: $31.30
Save: 10% off
+ GST
Add to Cart:
Although lung cancer remains the leading cancer killer in the United States, recent years have seen a number of developments that may portend future clinical benefit. These include renewed interest in CT-based screening approaches, the use of stereotactic radiation for early stage tumors, proposed revisions to the lung cancer staging system, and the development of molecular methods to predict chemotherapy sensitivity. Perhaps the most significant advance in the
treatment of this challenging disease is the introduction of molecularly targeted therapies, a term that includes monoclonal antibodies (mAbs) and tyrosine kinase inhibitors (TKIs). Specifically, drugs
targeting the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) are now FDA-approved for the treatment of advanced non-small cell lung cancer (NSCLC). Although these agents are generally better tolerated than conventional chemotherapy, their use requires a clear understanding of clinical data, mechanism, patient selection, drug interactions, and toxicities.Part of the Oxford American Pocket Notes series, this volume
provides a clinically-oriented overview of NSCLC targeted therapies to practicing oncologists. This ultra-concise guide contains insightful, easily accessible, evidence-based discussion on the mechanisms and proper use
for the newest agents to treat NSCLC. Key features include bulleted lists as well as numerous tables and figures to illustrate key points and provide the clinician with essential patient care tools.
Whilst every effort is made to keep pricing information up-to-date, prices and availability are subject to change without notice. Where prices or other details have changed from those listed on the website we will contact the customer and only proceed with the order after receiving acceptance of the revised pricing.
Targeted Therapy in Non-small Cell Lung Cancer
Home
Your IP Address is: 3.139.86.58
Copyright © 2024
Medical Books
. Powered by
Zen Cart